Moderate riskFDA DrugClass II

Fresenius Kabi sodium chloride injection recalled for sterility concerns

Fresenius Kabi is recalling specific batches of 0.9% Sodium Chloride Injection (saline solution) used in medical settings because the manufacturer cannot guarantee the product is sterile. The affected batches were distributed nationwide. No injuries have been reported so far.

From the FDA notice · Read the official notice ↗ · All Fresenius Kabi recalls

What to do

  1. If you use or administer this product, check the batch number and expiration date against the recall (Batch# 23DU10004, Exp 04/30/2026 or Batch# 23HU10006, Exp 06/30/2026)
  2. Do not use recalled batches; return them to your pharmacy or healthcare facility
  3. Contact your doctor or pharmacist if you have questions about your care

Is yours affected?

Compare your label or packaging with the recalled product.

Product
0.9% Sodium Chloride Injection, USP 900 mg per 100 mL (9 mg per mL) 500 mL in a Single Dose freeflex bag, 500 mL x 20, Manufactured for: Fresenius Kabi USA, LLC ("Fresenius Kabi"), IL 60047, Unit of Use NDC: 65219-432-20, Unit of Sale NDC Number: 65219-432-85.
Sold in
Nationwide
Made for
All ages (0 months and older)

This recall covers 14 products — see all of them.

Details

Illnesses reported
None reported
Manufactured in
3 Corporate Dr, Lake Zurich, IL, United States
Classification
Class II
Recall number
D-0432-2026

In the FDA's words

Description
0.9% Sodium Chloride Injection, USP 900 mg per 100 mL (9 mg per mL) 500 mL in a Single Dose freeflex bag, 500 mL x 20, Manufactured for: Fresenius Kabi USA, LLC ("Fresenius Kabi"), IL 60047, Unit of Use NDC: 65219-432-20, Unit of Sale NDC Number: 65219-432-85. Lack of Assurance of Sterility Batch# 23DU10004, Exp Date: 04/30/2026; Batch# 23HU10006, Exp Date: 06/30/2026. Distribution: US Nationwide , Alaska, and Puerto Rico.
Hazard
Lack of Assurance of Sterility

14 products in this recall

Fresenius Kabi IV saline and dextrose bags recalled over sterility

Fresenius Kabi is recalling 14 sodium chloride and dextrose IV fluid bags because the company cannot assure they are sterile. The products were sold under the Fresenius Kabi, BD and Fresenius Medical Care names and were distributed nationwide, to Alaska and to Puerto Rico. No injuries have been reported.

The agency lists each product separately. Check every one you might have.

More from Fresenius Kabi

See all

Related topics

SterilityDrugsSold nationwideMore from FDA Drug